Proto Labs Balance Sheet Health
Financial Health criteria checks 6/6
Proto Labs has a total shareholder equity of $680.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $753.8M and $73.8M respectively. Proto Labs's EBIT is $29.8M making its interest coverage ratio -13.6. It has cash and short-term investments of $100.5M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -13.6x |
| Cash | US$100.51m |
| Equity | US$679.99m |
| Total liabilities | US$73.79m |
| Total assets | US$753.79m |
Recent financial health updates
No updates
Recent updates
Proto Labs' (NYSE:PRLB) Performance Is Even Better Than Its Earnings Suggest
Nov 14
Proto Labs, Inc.'s (NYSE:PRLB) 36% Jump Shows Its Popularity With Investors
Nov 02Here's What's Concerning About Proto Labs' (NYSE:PRLB) Returns On Capital
Sep 08Proto Labs: Defensive Strategy Not Paying Off Yet
Aug 13Calculating The Intrinsic Value Of Proto Labs, Inc. (NYSE:PRLB)
Jul 18Proto Labs: Interesting Crossroads
May 28Proto Labs' (NYSE:PRLB) Solid Earnings Are Supported By Other Strong Factors
May 11Proto Labs, Inc.'s (NYSE:PRLB) Price In Tune With Revenues
Apr 13Proto Labs: Cash Flows Are Supporting The Stock
Mar 04Proto Labs: Excellent Business Feats Yet To Financially Materialize
Feb 16Proto Labs (NYSE:PRLB) May Have Issues Allocating Its Capital
Jan 03Proto Labs: Overlooked Digital Manufacturing Opportunity
Dec 04Proto Labs Remains Profitable Despite So Much Pessimism
Sep 25Proto Labs: The Rally Appears Overdone
Jul 14Be Wary Of Proto Labs (NYSE:PRLB) And Its Returns On Capital
Jul 13Is There An Opportunity With Proto Labs, Inc.'s (NYSE:PRLB) 41% Undervaluation?
May 06Proto Labs (NYSE:PRLB) Might Be Having Difficulty Using Its Capital Effectively
Apr 08Proto Labs Non-GAAP EPS of $0.26 beats by $0.05, revenue of $115.6M beats by $5.47M
Feb 10Proto Labs: Transitioning From A Fast Grower To A Slow Grower
Jan 20Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Dec 21Proto Labs Q3 2022 Earnings Preview
Nov 03Proto Labs: Improvement Of The Digital Model And Undervalued
Oct 27Is It Too Late To Consider Buying Proto Labs, Inc. (NYSE:PRLB)?
Sep 12Protolabs names new technology chief
Sep 08Some Investors May Be Worried About Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 05Proto Labs Q2 2022 Earnings Preview
Aug 04Proto Labs: Not A Great Prospect Until Profitability Issues Clear Up
Jul 07Is Proto Labs, Inc. (NYSE:PRLB) Potentially Undervalued?
May 24Proto Labs (NYSE:PRLB) Could Be Struggling To Allocate Capital
Mar 30The Prognosis For Proto Labs
Feb 22Returns On Capital At Proto Labs (NYSE:PRLB) Paint A Concerning Picture
Nov 28Is There Now An Opportunity In Proto Labs, Inc. (NYSE:PRLB)?
Nov 10Proto Labs: A Play On Additive Manufacturing
Nov 04Investors Could Be Concerned With Proto Labs' (NYSE:PRLB) Returns On Capital
Aug 29Some Investors May Be Willing To Look Past Proto Labs' (NYSE:PRLB) Soft Earnings
Aug 14Estimating The Fair Value Of Proto Labs, Inc. (NYSE:PRLB)
Aug 04Financial Position Analysis
Short Term Liabilities: PRLB's short term assets ($193.1M) exceed its short term liabilities ($53.8M).
Long Term Liabilities: PRLB's short term assets ($193.1M) exceed its long term liabilities ($20.0M).
Debt to Equity History and Analysis
Debt Level: PRLB is debt free.
Reducing Debt: PRLB had no debt 5 years ago.
Debt Coverage: PRLB has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PRLB has no debt, therefore coverage of interest payments is not a concern.